Wegovy maker Novo shares slump as management grilled on pricing, M&A ReutersWegovy Maker Novo Promises New Drugs to Boost Sales, but Investors Are Wary WSJNovo Nordisk targets more than five blockbuster drugs by 2030, CEO says Telegraph IndiaNovo Nordisk stock gets drilled on pipeline concerns — its CEO sees a main problem Yahoo FinanceNovo shares slide as drugmaker lays out post-Wegovy growth strategy CNBC
Market News
Wegovy maker Novo shares slump as management grilled on pricing, M&A
More News
US 10-year Treasury yield hits 5% for first time since 2023 as oil surge batters bonds
US: What’s Pushing Long-Term Bond Yields Higher?
Q1 Results Live Updates: Manappuram Finance Profit Jumps 41%, NBCC Revenue Dips 6%, Balrampur Chini Profit Drops 14%
Lay's, Kurkure, Maggi Expiry Dates Altered In Multi-Crore Racket In Mumbai